Status:
UNKNOWN
Quaternium-15, Use Test
Lead Sponsor:
Mekos Laboratories AS
Conditions:
Allergic Contact Dermatitis Towards Quaternium-15
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study is required by the FDA as part of a post-marketing commitment. The purpose of the study is to compare the reactivity of the TRUE Test quaternium-15 patch and a real use exposure.The subjects...
Eligibility Criteria
Inclusion
- Sensitivity to quaternium-15
- Age more than 18 years
Exclusion
- Topical or systemic treatment with corticosteroids or immunosuppresives.
- Treatment with UV-light
- Widespread active dermatitis or dermatitis on test area
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00311454
Start Date
April 1 2006
Last Update
April 6 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amtssygehuset i Gentofte
Gentofte Municipality, Gentofte, Denmark, 2900